Time in range, time in tight range and average glucose relationships are modulated by glycemic variability: identification of a glucose distribution model connecting glycemic parameters using real-world data.


Journal

Diabetes technology & therapeutics
ISSN: 1557-8593
Titre abrégé: Diabetes Technol Ther
Pays: United States
ID NLM: 100889084

Informations de publication

Date de publication:
05 Feb 2024
Historique:
medline: 5 2 2024
pubmed: 5 2 2024
entrez: 5 2 2024
Statut: aheadofprint

Résumé

Background Time in range (TIR), time in tight range (TITR) and average glucose (AG) are used to adjust glycemic therapies in diabetes. However, TIR/TITR and AG can show a disconnect, which may create management difficulties. We aimed to understand the factors influencing the relationships between these glycemic markers. Materials and methods Real-world glucose data were collected from self-identified diabetes individuals using flash continuous glucose monitoring (CGM). The effects of glycemic variability (GV), assessed as glucose coefficient of variation (CV), on the relationship between AG and TIR/TITR was investigated together with the best-fit glucose distribution model that addresses these relationships. Results Glucose readings were collected from 29,164 users (16,367 T1D, 11,061 T2D, and 1,736 others, 38,259 readings/subject). Comparing low and high CV tertiles, TIR at average glucose of 150 mg/dL varied from 80±5.6% to 62±6.8%, respectively (p<0.001), while TITR at average glucose of 130 mg/dL varied from 65±7.5% to 49±7.0%, respectively (p<0.001). In contrast, higher CV was associated with increased TIR and TITR at AG levels outside the upper limit of these ranges. Gamma distribution was superior to five other models fitting the glucose distribution and explained the observed trends, values, and non-linear interplay among CGM-derived glycemic metrics. Conclusions GV can significantly influence the relationship between AG and TIR with opposing effects according to AG levels, with the gamma model accurately predicting interactions among the different glycemic metrics. These data can potentially help the clinical management of individuals with diabetes, particularly when a mismatch between AG and TIR is apparent.

Identifiants

pubmed: 38315505
doi: 10.1089/dia.2023.0564
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Yongjin Xu (Y)

Abbott Diabetes Care Inc, 156054, Clinical Affairs, 1360 South Loop Road, Alameda, California, United States, 94502-7000; yongjinxu@hotmail.com.

Timothy C Dunn (TC)

Abbott Diabetes Care Inc, 156054, Clinical Affairs, 1360 S Loop Rd, Alameda, California, United States, 94502; tim.dunn@abbott.com.

Richard M Bergenstal (RM)

International Diabetes Center, 3800 Park Nicollet Blvd, Minneapolis , Minnesota, United States, 55416; richard.bergenstal@parknicollet.com.

Alan Cheng (A)

Abbott Diabetes Care Inc, 156054, Clinical Affairs, 1420 Harbor Bay Pkwy, Suite 346, Alameda, California, United States, 94502; alan.cheng@abbott.com.

Yaghoub Dabiri (Y)

Abbott Diabetes Care Inc, 156054, Clinical Affairs, Alameda, California, United States; yaghoub.dabiri@abbott.com.

Ramzi A Ajjan (RA)

University of Leeds, 4468, Leeds Institute of Cardiovascular and Metabolic Medicine, The LIGHT Laboratories, Clarendon Way, Leeds, United Kingdom of Great Britain and Northern Ireland, LS2 9JT; r.ajjan@leeds.ac.uk.

Classifications MeSH